Treatment-emergent AEs with BNZ-1 in patients with T-LGLL
| AE, n (%) . | Any grade . | Grade 3/4 . | Relation to BNZ-1 . |
|---|---|---|---|
| Neutropenia | 8 | 7 | 3 of 8, possibly |
| Decreased WBC | 4 | 3 | 1, possibly |
| Anemia | 8 | 4 | 3 possible and 1 probable |
| Alanine transaminase increase | 3 | 1 | 1 possible |
| Atrial fibrillation | 1 | 1 | Unrelated |
| Bilirubin increase | 1 | 1 | Possibly |
| Fever | 1 | 1 | Unrelated |
| Hypertension | 4 | 1 | 1 possible |
| Hypoglycemia | 1 | 1 | Possible |
| Joint swelling | 1 | 1 | Unrelated |
| Pneumonia | 1 | 1 | Unrelated |
| Total | 33 | 22 |
| AE, n (%) . | Any grade . | Grade 3/4 . | Relation to BNZ-1 . |
|---|---|---|---|
| Neutropenia | 8 | 7 | 3 of 8, possibly |
| Decreased WBC | 4 | 3 | 1, possibly |
| Anemia | 8 | 4 | 3 possible and 1 probable |
| Alanine transaminase increase | 3 | 1 | 1 possible |
| Atrial fibrillation | 1 | 1 | Unrelated |
| Bilirubin increase | 1 | 1 | Possibly |
| Fever | 1 | 1 | Unrelated |
| Hypertension | 4 | 1 | 1 possible |
| Hypoglycemia | 1 | 1 | Possible |
| Joint swelling | 1 | 1 | Unrelated |
| Pneumonia | 1 | 1 | Unrelated |
| Total | 33 | 22 |
WBC, white blood cell.